Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Authors not listed
Jaeb Center for Health Research · 2023
Abstract
Home optical coherence tomography- guided treatment versus treat and extend for the management of neovascular age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2023). Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD. <em>Jaeb Center for Health Research</em>. https://clinicaltrials.gov/study/NCT05904028
Vancouver
Anonymous. Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD. Jaeb Center for Health Research. 2023.
BibTeX
@misc{anon2023HomeOC,
title = {Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD},
author = {Anonymous},
journal = {Jaeb Center for Health Research},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
MidAtlantic Retina 2013
Open access · US-GOV
Optical Coherence Tomography Guided Treat and Extend Therapy for Neovascular Age Related Macular Degeneration Using Aflibercept (the ATLAS Study)
Ophthalmology 2006
Citation only
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Center for Eye Research Australia 2017
Open access · US-GOV
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Control Delivery Systems 2001
Open access · US-GOV
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
Drugs 2008
Citation only